Скачать презентацию Sepsis markers Dr Natalie Leung 6 th January Скачать презентацию Sepsis markers Dr Natalie Leung 6 th January

3cbb6b283ede3a9e708dde30532b6780.ppt

  • Количество слайдов: 91

Sepsis markers Dr. Natalie Leung 6 th January 2012 ICU, Pamela Youde Nethersole Eastern Sepsis markers Dr. Natalie Leung 6 th January 2012 ICU, Pamela Youde Nethersole Eastern Hospital, Hong Kong

Introduction • Sepsis can occur suddenly and deteriorate rapidly • Timely diagnosis of sepsis Introduction • Sepsis can occur suddenly and deteriorate rapidly • Timely diagnosis of sepsis is the key of success

However…… can sometimes be challenging However…… can sometimes be challenging

How to improve the outcome of sepsis? • Early diagnosis and treatment • Surviving How to improve the outcome of sepsis? • Early diagnosis and treatment • Surviving Sepsis Campaign – reduction in mortality rate of severe sepsis.

Septic shock: Mortality risk and time Early diagnosis is a key to reduce mortality Septic shock: Mortality risk and time Early diagnosis is a key to reduce mortality Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 2006; 34: 1589 -96

Sepsis markers • Diagnostic – Useful for identifying or ruling out sepsis – Identifying Sepsis markers • Diagnostic – Useful for identifying or ruling out sepsis – Identifying patients who may benefit from specific therapies • Assessing the response to therapy • Prognostic

Ideal sepsis markers • High sensitivity (increase pathologically in the presence of disease) • Ideal sepsis markers • High sensitivity (increase pathologically in the presence of disease) • High specificity (does not increase in the absence of disease) • Related to the disease burden and extent • Changes in accordance with the clinical evolution • Anticipates clinical changes before it happens

Ideal sepsis markers • Adds independent information about the risk or prognosis • Reproducible Ideal sepsis markers • Adds independent information about the risk or prognosis • Reproducible • Easy and cheap

What do we have now? • WCC • Lactate – Tissue perfusion variables • What do we have now? • WCC • Lactate – Tissue perfusion variables • Biomarkers – C-reactive protein (CRP) – Procalcitonin (PCT) – Cytokines – New markers

What do we have now? • A review of sepsis biomarkers – 178 different What do we have now? • A review of sepsis biomarkers – 178 different biomarkers – Most of them had been tested clinically • Primiarily as prognostic markers • Relatively few have been used for diagnosis Sepsis biomarkers: a review. Critical Care. 2010; 14(1): R 15

What do we have now? • Large numbers of markers – Cytokines – Receptors What do we have now? • Large numbers of markers – Cytokines – Receptors biomarkers – Coagulation biomarkers – Biomarkers related to vascular endothelial damage – Markers related to organ dysfunction – Acute phase protein biomarkers – others Sepsis biomarkers: a review Crit Care. 2010; 14(1): R 15

Sepsis biomarkers: a review Crit Care. 2010; 14(1): R 15 Sepsis biomarkers: a review Crit Care. 2010; 14(1): R 15

Sepsis biomarkers: a review Crit Care. 2010; 14(1): R 15 Sepsis biomarkers: a review Crit Care. 2010; 14(1): R 15

Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers

Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers

Lactate production Critical illness leading to increased tissue oxygen extraction Oxygen delivery Oxygen consumption Lactate production Critical illness leading to increased tissue oxygen extraction Oxygen delivery Oxygen consumption Oxygen debt Global tissue hypoxia Anaerobic metabolism Lactate production

Lactate • Raised in severe sepsis and septic shock – Hypoperfusion (secondary to anaerobic Lactate • Raised in severe sepsis and septic shock – Hypoperfusion (secondary to anaerobic metabolism) – Cellular metabolic failure – Decrease clearance by the liver

 • Numerous studies have established that lactate is a good marker of global • Numerous studies have established that lactate is a good marker of global hypoxia in circulatory shock

Use of lactate as a sepsis marker • Diagnosis • Prognostic and predict mortality Use of lactate as a sepsis marker • Diagnosis • Prognostic and predict mortality

Diagnosis • Limited role in diagnostic • Surviving Sepsis Campaign guidelines 2008 – “begin Diagnosis • Limited role in diagnostic • Surviving Sepsis Campaign guidelines 2008 – “begin resuscitation immediately in patients with hypotension/ elevated serum lactate >=4 mmol/l”

Prognostic and predict mortality • It can be used as … – Monitoring response Prognostic and predict mortality • It can be used as … – Monitoring response of septic patients to resuscitation – Stratification and prognosis • Serial lactate level monitoring is recommended – High lactate clearance: • less required vasopressors therapy, greater improvements in APACHE II scores and decreased mortality rates

Lactate clearance • In patients with septic shock – Survivors vs non-survivors • Initial Lactate clearance • In patients with septic shock – Survivors vs non-survivors • Initial lactate level did not differ much • Survivors had a significant decrease in lactate levels and less “lactate clearance time” Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients. Crit Care Med. 2003; 31(3): 705 -710.

Lactate clearance • 111 ED and ICU patients with severe sepsis and septic shock Lactate clearance • 111 ED and ICU patients with severe sepsis and septic shock • Lactate clearance – The percentage lactate decrease over the initial 6 hr ED evaluation and treatment period Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients. Crit Care Med. 2003; 31(3): 705 -710.

Lactate clearance • All patients were followed for 72 hrs and received a protocol-driver Lactate clearance • All patients were followed for 72 hrs and received a protocol-driver EGDT • Results – The higher the lactate clearance, the lower the mortality Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients. Crit Care Med. 2003; 31(3): 705 -710.

 • Single-center cohort study • 830 patients • Test the association between initial • Single-center cohort study • 830 patients • Test the association between initial serum lactate level and mortality in patients presenting to AED with severe sepsis is independent of organ dysfunction and shock

Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers

CRP • Acute phase protein • Synthesized in liver • IL-6 (and IL-1 and CRP • Acute phase protein • Synthesized in liver • IL-6 (and IL-1 and TNFα) stimulate synthesis • Binds bacterial polysaccharide/ chromatin – Activates the classical complement pathway – Increase the immune inflammatory response • Esp. in bacteria infection (vs viral)

CRP • Level of CRP begins within 4 -6 hrs after stimulus • Doubles CRP • Level of CRP begins within 4 -6 hrs after stimulus • Doubles every 8 hrs • Peaks at 36 -50 hrs • Half-life 19 hrs

CRP • A sensitive marker of inflammation and tissue damage • Other conditions result CRP • A sensitive marker of inflammation and tissue damage • Other conditions result in raised in CRP – Rheumatological disease • • SLE Systemic sclerosis Dermatomyositis Sjogren’s disease – Inflammatory bowel disease – Haematological disease • E. g. leukaemia – Graft-versus-host disease

CRP CRP

CRP as a marker of sepsis resolution CRP of non-survivors was significantly higher since CRP as a marker of sepsis resolution CRP of non-survivors was significantly higher since D 3 onward

Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers

Procalcitonin • A peptide precursor of calcitonin • Produced by – parafollicular cells of Procalcitonin • A peptide precursor of calcitonin • Produced by – parafollicular cells of the thyroid – neuroendocrine cells of the lung and the intestine (extrathyroidal) • It raises in a response to a proinflammatory stimulus – Esp of bacterial origin (mainly from the cells of lung and the intestine)

PCT- characteristics • Fast response (2 -4 hrs) • Peak values 8 -24 hr PCT- characteristics • Fast response (2 -4 hrs) • Peak values 8 -24 hr

PCT- characteristics • Short half-life (~24 hrs) independent of renal function • Easy to PCT- characteristics • Short half-life (~24 hrs) independent of renal function • Easy to measure in serum and plasma (stable in vivo and in vitro) • Plasma concentration ~ <0. 05 -1000 ng/ml

 • In systemic inflammation or in infection – Persists as long as inflammatory • In systemic inflammation or in infection – Persists as long as inflammatory process continues • Mechanical trauma – Increase within 2 -4 hrs – Peak in 1 st or 2 nd day then diminish

Procalcitonin (PCT) • Reference values (except newborn) – Significantly lower in leukopenic patients < Procalcitonin (PCT) • Reference values (except newborn) – Significantly lower in leukopenic patients < 0. 05 ng/ml Healthy individuals < 0. 5 ng/ml Probability of sepsis is low, local infection possible Grey zone, recheck 6 -12 hrs later Probability of sepsis is high 0. 5 -2 ng/ml >2 ng/ml

Use of PCT • Sepsis diagnosis • Antibiotic guidance • Patient prognosis Use of PCT • Sepsis diagnosis • Antibiotic guidance • Patient prognosis

Sepsis diagnosis • Prospective single centre, noninterventional study • Patients > 38 C Bruno Sepsis diagnosis • Prospective single centre, noninterventional study • Patients > 38 C Bruno Riou et al. Critical Care 2007; 11: R 60

Antibiotic therapy • Multicentre, prospective, parallel-group, open-label trial • 1: 1 ratio of procalcitonin Antibiotic therapy • Multicentre, prospective, parallel-group, open-label trial • 1: 1 ratio of procalcitonin (n=311) and control group (n=319)

 • Antibiotics were started/ stopped based on a predefined cut-off ranges of PCT • Antibiotics were started/ stopped based on a predefined cut-off ranges of PCT value • Primary end point – 28 and 60 days mortality – No. of days without antibiotics

Primary endpoint: all-cause mortality at 60 days Primary endpoint: all-cause mortality at 60 days

Antibiotic therapy and prognosis Charles PE, et al. Critical Care 2009: 13; 16 -20 Antibiotic therapy and prognosis Charles PE, et al. Critical Care 2009: 13; 16 -20 • 180 patients • PCT levels were obtained at the onset of clinical sepsis (Day 1) and at least twice more within next 3 days • Monitor change in PCT levels to assess effectiveness of antibiotic treatment

Mortality rates associated with the decline in PCT levels A 30% decrease in PCT Mortality rates associated with the decline in PCT levels A 30% decrease in PCT levels between Day 2 and 3 appears to be a good prognostic indicator of effective antibiotic therapy and associated with better survival

 • PCT is also associated with other conditions – VAP – Severe acute • PCT is also associated with other conditions – VAP – Severe acute pancreatitis – Acute exacerbation of COPD

Nonbacterial infection: Viruses, Fungi, Parasites • PCT tend to be low in viral infection Nonbacterial infection: Viruses, Fungi, Parasites • PCT tend to be low in viral infection – However, in systemic viral infection, PCT value can as high as 16 ng/ml • A low serum PCT cannot be used to exclude bacterial from viral infections but that a combination of PCT, CRP, white blood cell count, and clinical illness scoring might be more useful

Nonbacterial infection: Viruses, Fungi, Parasites • In patients with fungal infections, results have been Nonbacterial infection: Viruses, Fungi, Parasites • In patients with fungal infections, results have been variable • Infection with the malaria parasite often leads to very high levels of serum, as high as 662 ng/m. L

Sepsis and PCT: The Pediatric Experience • Complicated by a physiological rise in both Sepsis and PCT: The Pediatric Experience • Complicated by a physiological rise in both term and preterm, healthy infants, which peaks at approximately 24 h and returns to normal by day 3

Sepsis and PCT: The Pediatric Experience • Variable in sensitivity and specificity • Some Sepsis and PCT: The Pediatric Experience • Variable in sensitivity and specificity • Some authors recommended against the use of PCT in routine diagnosis of bacterial sepsis in neonates, because of more complicated PCT measurement and its expense in comparison with CRP.

Different features of CRP and PCT • CRP levels may not further increase during Different features of CRP and PCT • CRP levels may not further increase during more severe stages of sepsis. • PCT rises the diagnosticto the severity of in proportion capacity of PCT is Therefore, sepsis andto that of CRP due to the close superior reaches its highest levels in septic shock. between PCT levels and the correlation severity of sepsis and outcome.

Different features of CRP and PCT • PCT reacted more quickly than CRP • Different features of CRP and PCT • PCT reacted more quickly than CRP • PCT concentrations had their maximum Allows anticipation levels prior to those of CRP of a diagnosis of sepsis 24 -48 hours before the CRP level would Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction Crit Care. 2004; 8(4): 234– 42.

Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers Sepsis markers • • Lactate C-reactive protein (CRP) Procalcitonin (PCT) Newer sepsis markers

New sepsis markers • Soluble CD 14 subtype (Generic name. Presepsin) • Heparin-Binding protein New sepsis markers • Soluble CD 14 subtype (Generic name. Presepsin) • Heparin-Binding protein • Others

Soluble CD 14 subtype Soluble CD 14 subtype

Early diagnosis and prognosis Early diagnosis and prognosis

Early diagnosis and prognosis Early diagnosis and prognosis

 • ROC analysis comparing the accuracy for the prediction of 30 -day mortality • ROC analysis comparing the accuracy for the prediction of 30 -day mortality revealed areas under the receiver operating characteristics curve (AUC) for presepsin, APACHE II score and procalcitonin of 0. 878, 0. 815 and 0. 661, respectively.

Quick turn around timefor emergency and intensive care use Quick turn around timefor emergency and intensive care use

Heparin-binding protein • An early marker of circulatory failure in sepsis • Release from Heparin-binding protein • An early marker of circulatory failure in sepsis • Release from activated neutrophils – A potent inducer of vascular leakage – Resulted in extravasation of plasma and WBC to the focus of infection

Clinical Infectious Diseases 2009; 49: 1044 -50 Clinical Infectious Diseases 2009; 49: 1044 -50

Clinical Infectious Diseases 2009; 49: 1044 -50 Clinical Infectious Diseases 2009; 49: 1044 -50

HBP is an early diagnostic and prognostic marker HBP is an early diagnostic and prognostic marker

How about other markers? How about other markers?

 • TNF-a – The initiating factor in the activation of host response and • TNF-a – The initiating factor in the activation of host response and subsequent cytokine release during infection – Concentration increase 24 times after LPS challenge during in vivo experimental endotoxemia

However, the diagnostic utility of TNF is insufficient for distinguishing infectious inflammation Why? • However, the diagnostic utility of TNF is insufficient for distinguishing infectious inflammation Why? • Short half-life of 17 min – Short-term concentration in response to bacterial challenge

 • Interleukin-6 – – – Increased concentrations correlating to infection Activation time: very • Interleukin-6 – – – Increased concentrations correlating to infection Activation time: very short Half-life time ~ 1 hr Sensitive early diagnosis of neonatal sepsis Adult values • Sepsis 300 -2700 ng/L • SIRS 100 ng/L – Usefulness in adult diagnosis has not well established. Interleukin-6 concentrations in neonatal sepsis. Lancet 353; 9148: 239 -40

Conclusion • Sepsis is associated with significant mortality and morbidity • Sepsis markers can Conclusion • Sepsis is associated with significant mortality and morbidity • Sepsis markers can aid in the diagnosis of sepsis • It may provide prognostic value • Many new sepsis markers are under investigation

 • Procalcitonin is a well-established biomarker of sepsis that fulfills several criteria of • Procalcitonin is a well-established biomarker of sepsis that fulfills several criteria of clinical needs – it responds both to infection and severity of infection – antibiotic treatment can also be guided by PCT – Prognostic value

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medicine 2008; 36: 269 -327

The End Thank you The End Thank you

Different features of CRP and PCT • CRP concentrations were high already during the Different features of CRP and PCT • CRP concentrations were high already during the less severe stages of organ dysfunction and systemic inflammation – values useful much further increased during the CRP less were not in distinguishing evolution of more severe stages of disease. sepsis in severe sepsis and septic shock • PCT levels correlates with the stages of disease (especially increased in patients with organ dysfunction, severe sepsis or septic shock. ) Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction Crit Care. 2004; 8(4): 234– 42.

Different features of CRP and PCT • PCT concentrations more rapidly declined as compared Different features of CRP and PCT • PCT concentrations more rapidly declined as compared with CRP remained high even in the late stage of disease Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction Crit Care. 2004; 8(4): 234– 42.

Prognosis • PCT levels were significantly associated with – – admission to a special Prognosis • PCT levels were significantly associated with – – admission to a special care unit duration of intravenous antibiotic use total duration of antibiotic treatment length of hospital stay, whereas CRP was related only to the latter two variables. • These data suggest that PCT may be a valuable addition to currently used markers of infection for diagnosis of infection and prognosis in patients with fever at the AED Critical Care Med 2010; 38: 457– 463

Clinical Infectious Diseases 2009; 49: 1044 -50 Clinical Infectious Diseases 2009; 49: 1044 -50